Suchergebnisse
Organon & Co. Shareholders Clear Sun Pharma Merger Deal
Key Points
- Interested in Organon & Co.? Here are five stocks we like better.
- Organon shareholders approved the company’s proposed merger with Sun Pharmaceutical Holdings USA, clearing a major
Viracta Therapeutics Inc.
WKN: A2QQRS / Symbol: SNSS / Name: Viracta Therapeutics Inc. / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,008 €
-


